| Issue Date |
Title |
Author(s) |
| May-2021 |
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma |
Liu, Dan;Ma, Chunguang;Lu, Ping;Gong, Jifang;Ye, Dingwei;Wang, Siyang;Peng, Peijian;Bai, Yuxian;Song, Yuqin;Chen, Jianhua;Jiang, Ou;Zhang, Guojun;Ba, Yi;Chen, Li;Pan, Jianji;Li, Qi;Zhang, Liling;Gu, Shanzhi;Yin, Xianli;Cao, Bangwei;Han, Weiqing;Dong, Haiying;Guo, Jianming;Zhang, Huilai;Su, Hang;Jiang, Yongsheng;Ouyang, Weiwei;Ma, Lulin;Sun, Yan;Zhang, Feng;Lv, Jun;Guo, Yabing;Xu, Chongyuan;Qi, Junyuan;Wang, Li;Wang, Xiang;Liu, Zhen;Shen, Lin |
| Aug-2020 |
GLS-010, a novel fully human anti-PD-1 mAb in patients with advanced tumor: Preliminary results of a Phase Ib clinical trial |
Shen, Lin;Gong, Jifang;Song, Yuqin;Ye, Dingwei;Lu, Zhihao;Wang, Siyang;Peng, Peijian;Chen, Jianhua;Jiang, Ou;Zhang, Guojun;Bai, Yuxian;Pan, Jianji;Ma, Chunguang;Chen, Li;Ma, Yi;Li, Qi;Lu, Ping;Zhang, Lingli;Yin, Xianli;Gu, Shanzhi;Zhang, Huilai;Su, Hang;Jiang, Yongsheng;Cao, Bangwei;Han, Weiqing;Sun, Yan;Zhang, Feng;Ouyang, Weiwei;Dong, Haiying;Guo, Jianming;Guo, Yabing;Xu, Chongyuan;Qi, Junyuan;Wang, Li;Lv, Jun;Wang, Xiang;Chen, Chris;Li, Jing;Zheng, Yong;Jin, Ge;Yang, Yining;Zhao, Guodong;Yang, Fan;Xu, Kehui;Liang, Xiangying;Pan, Zhaoyang;Meng, Haijin |
| 2013 |
Recombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation |
Li, Jinluan;Pan, Jianji;Zhu, Xianggao;Su, Ying;Bao, Lingling;Qiu, Sufang;Zou, Changyan;Cai, Yong;Wu, Junxin;Tham, Ivan W. K. |
| Aug-2023 |
A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China |
Zhang, Zizhu;Chong, Yizheng;Liu, Yuanhao;Pan, Jianji;Huang, Cheng;Sun, Qi;Liu, Zhibo;Zhu, Xiayang;Shao, Yujun;Jin, Congjun;Liu, Tong |
